Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations.
about
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complicationsCatechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's diseaseMedical management of Parkinson's diseaseEntacapone.Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.Interventions to achieve tonic exposure to levodopa: delaying or preventing the onset of motor complications.Drug development for neurodegenerative diseases: role of PET.Catechol-O-methyltransferase (COMT) inhibitors in Parkinson's disease.Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson's diseasePharmacological treatment of Parkinson's disease.Seniors with Parkinson's disease: initial medical treatment.The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's diseaseEntacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month studyMotor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?One-year open-label study of entacapone in patients with advanced Parkinson disease.L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum.Pharmacological approaches to disease-modifying therapies in Parkinson's disease.Patient diaries as a clinical endpoint in Parkinson's disease clinical trials.Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa doseThe effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF.Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).Levodopa/carbidopa/entacapone in Parkinson's disease.Immediate versus delayed switch from levodopa/carbidopa to levodopa/carbidopa/entacapone: effects on motor function and quality of life in patients with Parkinson's disease with end-of-dose wearing off.Therapeutic advances in idiopathic Parkinsonism.
P2860
Q24234273-6BA04122-AA52-44F5-99D7-EEA4CE5F0339Q24245911-54171F93-8E14-41DF-8175-C0242D1B1A15Q24647827-09ACB1C5-B8E4-4C9D-B3FE-11C51690E8F4Q31440112-9EBE647E-B849-49AF-9C01-5818713FA085Q31913303-CFA23DD6-72F7-4F5A-8318-799015CDA85FQ33771370-751C0435-AE79-4E02-A003-12F7FB55F186Q33841672-2904D686-8CA1-4FF3-8FD4-FD2005ABCE32Q33944053-A6B39876-52BF-4554-B1E4-94A665E27BD6Q34041790-68F43A2E-E756-451C-AE77-44846F9FC750Q34048261-C16BE96D-66A8-40C2-B2CE-78E79AC715F2Q34508143-DCF49A53-EFFA-4AD1-B437-7FC2D97D7C9BQ35456745-AF63A0F5-EFA0-452C-9E16-782B20F8A184Q35475549-B6A47513-ABA5-47A8-8108-9E7CD5C8F698Q37115650-8C4E4D52-0AB3-4884-A68C-F48AD2C16504Q37203293-61E5DE74-51C5-40A7-8C7B-C2CB78211017Q37486030-05515DFC-0F1D-4584-AE27-F99DE32FA715Q37610212-3DFB746F-3674-429C-9EAE-DB3D65BD19BAQ37954392-E0D1F8A6-7DF3-4C56-9411-CFD3F1A07314Q42099300-5E2BB9C5-AB7E-4BA6-94C6-207B2FDCDE0CQ43193465-92583408-E2AB-46B1-8D77-3D9FD3E43548Q43951950-0580B9D5-2184-47EA-BEF3-B2ED6B9A6154Q45934197-AE75DE49-B245-4C02-AF17-E05959010F94Q46119482-698EE9FB-4149-4B83-ADCE-C5EB5C1DA63FQ49115429-C1D5AEA1-D58F-4AF5-98CA-CB532F98D59F
P2860
Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Entacapone prolongs levodopa r ...... levodopa related fluctuations.
@en
type
label
Entacapone prolongs levodopa r ...... levodopa related fluctuations.
@en
prefLabel
Entacapone prolongs levodopa r ...... levodopa related fluctuations.
@en
P2860
P356
P1476
Entacapone prolongs levodopa r ...... levodopa related fluctuations.
@en
P2093
H M Ruottinen
P2860
P356
10.1136/JNNP.60.1.36
P407
P577
1996-01-01T00:00:00Z